Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 8.38% vs -10.02% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 96.65% vs -37.05% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 32.56% vs -18.80% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 11.36% vs 2.33% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Dermapharm Holding SE With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 8.38% vs -10.02% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -5.36% vs 9.53% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 96.65% vs -37.05% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 25.30% vs 34.98% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 32.56% vs -18.80% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -1.38% vs 14.01% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 11.36% vs 2.33% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -7.55% vs -1.24% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






